EP. 1: Understanding Seladelpar as a Second-Line Treatment for PBC
Trivedi and Lawitz discuss seladelpar’s mechanism of action and its use as a second-line therapy in PBC.
EP. 2: The Clinical Impact of Seladelpar in PBC Care
Trivedi and Lawitz discuss the clinical impact of having seladelpar as a second-line treatment option for patients with PBC.
EP. 3: What Sets Seladelpar Apart From Other PBC Therapies
Trivedi and Lawitz discuss what sets seladelpar apart from other PBC therapies in the rapidly evolving treatment landscape.
EP. 4: Insights from Long-Term ASSURE Data for Seladelpar
Trivedi and Lawitz review long-term data from the phase 3 open-label ASSURE study and explain what they add to our understanding of seladelpar for PBC.
